- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 17.10. | NT PHARMA (01011): RESIGNATION OF (1) COMPANY SECRETARY, (2) AUTHORISED REPRESENTATIVE AND (3) AGENT FOR THE ACCEPTANCE OF SERVICE OF PROCESS AND NOTICES ... | 1 | HKEx | ||
| 17.10. | NT PHARMA (01011): UPDATE IN RELATION TO THE DISCLAIMER OF OPINION ON GOING CONCERN SET OUT IN THE ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2024 | 1 | HKEx | ||
| 05.09. | NT PHARMA (01011): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDER | - | HKEx | ||
| 05.09. | NT PHARMA (01011): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDER | - | HKEx | ||
| CHINA NT PHARMA Aktie jetzt für 0€ handeln | |||||
| 05.09. | NT PHARMA (01011): INTERIM REPORT 2025 | 1 | HKEx | ||
| 19.08. | NT PHARMA (01011): INSIDE INFORMATION AND RESUMPTION OF TRADING | 1 | HKEx | ||
| 19.08. | NT PHARMA (01011): TRADING HALT | - | HKEx | ||
| 18.08. | NT PHARMA (01011): CHANGE OF ADDRESS OF THE PRINCIPAL PLACE OF BUSINESS AND HEADQUARTERS | 1 | HKEx | ||
| 08.08. | NT PHARMA (01011): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2025 | - | HKEx | ||
| 30.07. | NT PHARMA (01011): VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE | 2 | HKEx | ||
| 29.07. | NT PHARMA (01011): DATE OF BOARD MEETING | 1 | HKEx | ||
| 30.06. | NT PHARMA (01011): DELAY IN DESPATCH OF CIRCULAR | - | HKEx | ||
| 30.06. | NT PHARMA (01011): TERMS OF REFERENCE OF NOMINATION COMMITTEE | 1 | HKEx | ||
| 30.06. | NT PHARMA (01011): CHANGE IN COMPOSITION OF BOARD COMMITTEE | - | HKEx | ||
| 30.06. | NT PHARMA (01011): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION | 1 | HKEx | ||
| 30.06. | NT PHARMA (01011): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 30 JUNE 2025 | - | HKEx | ||
| 19.05. | NT PHARMA (01011): CHANGE OF CHIEF EXECUTIVE OFFICER | 1 | HKEx | ||
| 09.05. | NT PHARMA (01011): VOLUNTARY ANNOUNCEMENT | 1 | HKEx |
18 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 4,370 | +1,63 % | Aurora Cannabis Inc.: Aurora Announces Investment into German Manufacturing Facility | NASDAQ| TSX: ACB
Facility investment includes adopting the company's unmatched global manufacturing practices for superior cannabis production and quality
EDMONTON... ► Artikel lesen | |
| CANOPY GROWTH | 1,082 | -0,18 % | Cannabis-Aktien mit Trump-Schub: Bioxyne, Aurora und Canopy Growth im Fokus | ||
| HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
| TILRAY BRANDS | 1,185 | +1,07 % | Mehr als "nur" Cannabis-Blüten - Bioxyne setzt auf Produktvielfalt im Wettbewerb mit Tilray, High Tide und Aurora | ||
| DIGICANN VENTURES | 0,004 | 0,00 % | Digicann Ventures Inc.: Digicann Ventures Agrees to Mutual Termination of Business Combination Agreement with 3Win Corp. and D-3 Merger Sub, Inc. | Vancouver, British Columbia--(Newsfile Corp. - October 29, 2025) - Digicann Ventures Ltd. (CSE: DCNN) ("Digicann" or the "Company"), a company focused on opportunities within and outside of the cannabis... ► Artikel lesen | |
| WPD PHARMACEUTICALS | 0,002 | 0,00 % | WPD Pharmaceuticals Inc (2): WPD Pharmaceuticals suspended by CSE | ||
| SINOPHARM | 2,136 | -0,88 % | SINOPHARM (01099): ANNOUNCEMENT PRINCIPAL UNAUDITED ACCOUNTING DATA AND FINANCIAL INDICATORS OF SINOPHARM ACCORD FOR THE THIRD QUARTER OF 2025 | ||
| INDIVA | 0,016 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 20.06.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 20.06.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 20.06.2025.ISIN NameCA45580J1012 INDIVA... ► Artikel lesen | |
| CSPC PHARMA | 0,872 | +1,85 % | CSPC PHARMA (01093): UNAUDITED FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2025 | ||
| ORAMED PHARMACEUTICALS | 2,018 | -2,04 % | Scilex Holding Company Announces the Completion of the First Tranche of the Oramed Pharmaceuticals, Inc. Warrant Repurchase | PALO ALTO, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company ("Scilex" or the "Company") (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and... ► Artikel lesen | |
| ADASTRA | 0,132 | -3,65 % | Adastra Holdings Ltd.: Adastra Holdings Announces Completion of Sale of Subsidiaries | Langley, British Columbia--(Newsfile Corp. - October 15, 2025) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2E0) (the "Company") announces that it has completed the sale of all of the issued and outstanding... ► Artikel lesen | |
| CATALYST PHARMACEUTICALS | 18,395 | +0,03 % | Catalyst Pharmaceuticals, Inc.: Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE (amifampridine) Patent Litigation with Lupin Pharmaceuticals | CORAL GABLES, Fla., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing... ► Artikel lesen | |
| METRIOPHARM | - | - | MetrioPharm gains orphan drug status from EMA for MP1032 | ||
| METSERA | 63,11 | -1,07 % | Kreise: Novo Nordisk will Pfizer Biotech-Unternehmen Metsera wegschnappen | LONDON (dpa-AFX) - Der Pharmakonzern Novo Nordisk will sein Geschäft mit Abnehmmedikamenten laut Insidern durch die Übernahme der Biotechfirma Metsera schützen. Denn damit würden die Dänen Metsera... ► Artikel lesen | |
| NOVO NORDISK | 42,850 | +0,63 % | JEFFERIES stuft NOVO NORDISK auf 'Underperform' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Novo Nordisk von 415 auf 290 norwegische Kronen gesenkt und die Einstufung auf "Underperform" belassen. Der Patentauslauf... ► Artikel lesen |
CHINA NT PHARMA GROUP CO LTD gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CHINA NT PHARMA GROUP CO LTD finden Sie auf Wallstreet Online.